These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9122204)

  • 41. Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors.
    Xiao JH; Feng X; Di W; Peng ZH; Li LA; Chambon P; Voorhees JJ
    EMBO J; 1999 Mar; 18(6):1539-48. PubMed ID: 10075925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
    Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
    Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
    Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7.
    Quan T; He T; Voorhees JJ; Fisher GJ
    J Biol Chem; 2001 Jul; 276(28):26349-56. PubMed ID: 11320083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.
    Siegel PM; Shu W; Cardiff RD; Muller WJ; Massagué J
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8430-5. PubMed ID: 12808151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells.
    Liu Q; Huang SS; Huang JS
    J Biol Chem; 1997 Jul; 272(30):18891-5. PubMed ID: 9228067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth inhibition.
    Zhao Y; Young SL
    J Biol Chem; 1996 Feb; 271(5):2369-72. PubMed ID: 8576191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells.
    Ammanamanchi S; Tillekeratne MP; Ko TC; Brattain MG
    Cancer Res; 2004 Apr; 64(7):2509-15. PubMed ID: 15059906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
    Tam BY; Philip A
    J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.
    MacKay SL; Auffenberg T; Tannahill CL; Ksontini R; Josephs MD; Nowak M; Moldawer LL; Copeland EM
    Ann Surg; 1998 Jun; 227(6):781-9. PubMed ID: 9637541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
    DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion.
    Rao JN; Li L; Bass BL; Wang JY
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1034-44. PubMed ID: 11003584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
    Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes.
    Luckett-Chastain LR; Cottrell ML; Kawar BM; Ihnat MA; Gallucci RM
    Exp Dermatol; 2017 Aug; 26(8):697-704. PubMed ID: 27892604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
    Maeda M; Shintani Y; Wheelock MJ; Johnson KR
    J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
    J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
    Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
    Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.